AWH · Categories · Form 4

AWH - SEC Form 4 insider transactions

Aspira Women's Health Inc. (AWH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AWH

• 439d
  Director Vos Ellen O'Connor converted options into 5,313 shares, increasing direct ownership by 8% to 68,677 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  Director Parnell Winfred converted options into 5,156 shares, increasing direct ownership by 8% to 66,053 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  Director Beausang Ellen converted options into 1,615 shares (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  SEC Form 4 filed by Director Beausang Ellen

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  Director Ragard John Phillip converted options into 4,843 shares, increasing direct ownership by 4% to 129,890 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  Director Cavanaugh Stefanie L. converted options into 5,938 shares, increasing direct ownership by 9% to 72,789 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  Director Fralick Celeste Rachelle converted options into 5,000 shares, increasing direct ownership by 10% to 55,665 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 439d
  Director Herchuk Jannie Prestridge converted options into 8,438 shares, increasing direct ownership by 13% to 74,065 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 461d
  SEC Form 4 filed by Large owner Schuler Jack W

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 501d
  Amendment: Interim CEO Milligan Sandra converted options into 20,000 shares and covered exercise/tax liability with 6,356 shares (SEC Form 4)

  4/A - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Director Herchuk Jannie Prestridge converted options into 8,437 shares, increasing direct ownership by 15% to 65,627 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Director Fralick Celeste Rachelle converted options into 5,000 shares, increasing direct ownership by 11% to 50,665 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Director Parnell Winfred converted options into 5,157 shares, increasing direct ownership by 9% to 60,897 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Director Cavanaugh Stefanie L. converted options into 5,937 shares, increasing direct ownership by 10% to 66,851 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Director Ragard John Phillip converted options into 4,844 shares, increasing direct ownership by 4% to 125,047 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Interim CEO & President Milligan Sandra converted options into 20,000 shares (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 522d
  Director Vos Ellen O'Connor converted options into 5,312 shares, increasing direct ownership by 9% to 63,364 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 569d
  Amendment: Director Ragard John Phillip converted options into 4,844 shares, increasing direct ownership by 4% to 120,203 units (SEC Form 4)

  4/A - Aspira Women's Health Inc. (0000926617) (Issuer)
• 577d
  SEC Form 4 filed by Interim CFO Kallassy John A

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 578d
  SEC Form 4 filed by President Milligan Sandra

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 594d
  SEC Form 4 filed by President Milligan Sandra

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 594d
  SEC Form 4 filed by Chief Executive Officer Sandford Nicole

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 619d
  Director Vos Ellen O'Connor converted options into 5,313 shares, increasing direct ownership by 10% to 58,052 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 620d
  Director Cavanaugh Stefanie L. converted options into 5,938 shares, increasing direct ownership by 11% to 60,914 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 620d
  Director Parnell Winfred converted options into 5,156 shares, increasing direct ownership by 10% to 55,740 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 620d
  Director Herchuk Jannie Prestridge converted options into 8,438 shares, increasing direct ownership by 17% to 57,190 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 620d
  Director Ragard John Phillip converted options into 4,844 shares, increasing direct ownership by 4% to 120,203 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 620d
  Director Fralick Celeste Rachelle converted options into 5,000 shares, increasing direct ownership by 12% to 45,665 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 657d
  SEC Form 4 filed by Director Vos Ellen O'Connor

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 658d
  SEC Form 4 filed by Director Parnell Winfred

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 658d
  SEC Form 4 filed by Director Ragard John Phillip

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 658d
  SEC Form 4 filed by Interim CFO Kallassy John A

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 658d
  SEC Form 4 filed by Director Herchuk Jannie Prestridge

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 658d
  SEC Form 4 filed by Director Fralick Celeste Rachelle

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 658d
  SEC Form 4 filed by Director Cavanaugh Stefanie L.

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 670d
  Director Fralick Celeste Rachelle was granted 15,381 shares, increasing direct ownership by 61% to 40,665 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 670d
  Director Parnell Winfred was granted 15,803 shares, increasing direct ownership by 45% to 50,584 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 670d
  Director Herchuk Jannie Prestridge was granted 20,017 shares, increasing direct ownership by 70% to 48,752 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 670d
  Director Cavanaugh Stefanie L. was granted 16,804 shares, increasing direct ownership by 44% to 54,976 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 670d
  Director Vos Ellen O'Connor was granted 16,593 shares, increasing direct ownership by 46% to 52,739 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 704d
  Director Parnell Winfred was granted 3,268 shares, increasing direct ownership by 10% to 34,781 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 704d
  Director Herchuk Jannie Prestridge was granted 4,902 shares, increasing direct ownership by 21% to 28,735 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 704d
  Director Vos Ellen O'Connor was granted 3,268 shares, increasing direct ownership by 10% to 36,146 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 705d
  Director Cavanaugh Stefanie L. was granted 3,268 shares, increasing direct ownership by 9% to 38,172 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 705d
  CEO Sandford Nicole was granted 13,072 shares, increasing direct ownership by 19% to 83,668 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 730d
  SEC Form 4 filed by Chief Financial Officer Hombeck Torsten

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 761d
  SEC Form 4 filed by Hombeck Torsten

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 761d
  SEC Form 4 filed by Sandford Nicole

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 769d
  SEC Form 4 filed by Milligan Sandra

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 846d
  SEC Form 4 filed by Sandford Nicole

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 851d
  SEC Form 4 filed by Hombeck Torsten

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 851d
  SEC Form 4 filed by Merchant Minh Hoang

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 898d
  Fralick Celeste Rachelle was granted 13,252 shares, increasing direct ownership by 110% to 25,284 units (SEC Form 4) (Amendment)

  4/A - Aspira Women's Health Inc. (0000926617) (Issuer)
• 900d
  Jordan Veronica Gh was granted 7,045 shares, increasing direct ownership by 20% to 41,620 units (SEC Form 4) (Amendment)

  4/A - Aspira Women's Health Inc. (0000926617) (Issuer)
• 919d
  Merchant Minh Hoang sold $3,303 worth of shares (980 units at $3.37) (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 937d
  Hombeck Torsten was granted 30,000 shares, increasing direct ownership by 1,000% to 33,000 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 937d
  Merchant Minh Hoang was granted 10,000 shares, increasing direct ownership by 59% to 26,865 units (SEC Form 4)

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 937d
  SEC Form 4 filed by Sandford Nicole

  4 - Aspira Women's Health Inc. (0000926617) (Issuer)
• 989d
  Sandford Nicole was granted 26,467 shares, increasing direct ownership by 97% to 53,703 units (SEC Form 4) (Amendment)

  4/A - Aspira Women's Health Inc. (0000926617) (Issuer)
• 989d
  Sandford Nicole was granted 0 shares (SEC Form 4) (Amendment)

  4/A - Aspira Women's Health Inc. (0000926617) (Issuer)

Other AWH categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends